S-1/A: Callan JMB Secures $25M Equity Line with Hexstone Capital

Callan JMB Inc. filed an S-1/A amendment, revealing a new $25 million equity purchase agreement with Hexstone Capital, LLC and a related registration rights agreement.

Summary

• Amendment No. 1 to Form S-1 (File No. 333-289849) is an exhibits-only filing, primarily incorporating new financing agreements.
• The Company entered into a Purchase Agreement with Hexstone Capital, LLC, dated July 24, 2025, for the sale of up to $25,000,000 of its common stock.
• The Company has the right, but not the obligation, to direct the Investor to purchase shares in 'Regular Purchases' ranging from $500,000 to $2,000,000, as often as every business day, subject to conditions.
• The 'Regular Purchase Price' is 95% of the lowest daily Volume-Weighted Average Price (VWAP) during a specified measurement period, with a 'Floor Price' of $1.00.
• The Company can also make 'Exemption Purchases' up to an aggregate of $1,000,000, with the first allowed on the closing date of the agreement, at 95% of the lowest daily VWAP during its measurement period.
• The Investor's beneficial ownership is limited to no more than 4.99% of the outstanding common stock.
• The Investor is prohibited from short selling or hedging transactions related to the Company's common stock during the agreement term.
• A Registration Rights Agreement, also dated July 24, 2025, obligates the Company to register the purchased shares for resale by the Investor.
• The Company must reserve 6,000,000 shares of common stock for issuance under the agreement.
• The Company will reimburse the Investor for transaction expenses up to $50,000, with $15,000 already paid.
• The Investor's monthly sales of common stock are limited to the greater of $25,000 per trading day or 17.5% of daily trading volume.
• The agreement automatically terminates on the 18-month anniversary of the Commencement Date if the full $25,000,000 is not purchased.
• A termination fee of $250,000 is payable by the Company if it terminates the agreement before selling $7,500,000, unless due to beneficial ownership limitations.
• The Company is prohibited from effecting or entering into agreements for 'Variable Rate Transactions' (dilutive financing) during the agreement term, with specific exemptions for equity incentive plans, existing securities, and strategic transactions.
• The Company must secure and maintain the listing of all issued shares on the Principal Market (Nasdaq Capital Market) and comply with its rules.
• Penalties, including the issuance of 25,000 'Filing Default Shares' or 'Effectiveness Default Shares,' are specified if the Company fails to timely file or make effective the registration statement for resale.

Sentiment

Score: 6

Explanation: The company secured a significant equity financing facility, providing access to capital. However, the dilutive nature of the pricing mechanism (95% of VWAP) and the potential for continuous selling pressure from the investor, albeit capped, introduce some negative sentiment. The prohibition on variable rate transactions is a positive for existing shareholders.

Positives

• Secured a potential $25 million equity financing facility, providing a significant source of capital for corporate purposes.
• The financing mechanism offers flexibility, allowing the Company to draw funds as needed through regular and exemption purchases.
• The Investor is committed to purchasing shares, subject to the agreement's conditions, ensuring a potential funding source.
• The prohibition on variable rate transactions (with specific exemptions) protects existing shareholders from certain types of highly dilutive future financings.
• The Investor is restricted from short selling or hedging transactions, which could help mitigate downward pressure on the stock price from the Investor's activities.

Negatives

• The purchase price for shares is at a discount (95% of the lowest daily VWAP), which is inherently dilutive to existing shareholders.
• The Company's discretion on when to issue purchase notices means the timing and amount of capital raised are not guaranteed, depending on market conditions and the Company's needs.
• A termination fee of $250,000 is payable by the Company if it terminates the agreement early without raising $7.5 million, creating a financial obligation.
• While the Investor's sales are capped, the continuous nature of the offering could still lead to sustained selling pressure on the Company's stock.
• A 'Floor Price' of $1.00 for regular purchases means the Company cannot sell shares under this mechanism if the stock price drops below this level, potentially limiting access to capital when it might be most needed.

Risks

• Market Price Volatility: The purchase price is tied to VWAP, meaning the Company sells shares at a discount to prevailing market prices, which could be exacerbated by market volatility and lead to greater dilution.
• Dilution: Continuous issuance of shares under the agreement, up to $25 million, will dilute existing shareholders' ownership and could negatively impact earnings per share.
• Regulatory Compliance: Failure to maintain SEC registration effectiveness or Principal Market listing could trigger penalties and limit the Company's access to funds under the agreement.
• Liquidity Risk: Although the Investor's sales are capped, the continuous nature of the offering could still create a steady supply of shares in the market, potentially impacting liquidity and stock price.
• Floor Price Limitation: If the common stock trades below $1.00, the Company cannot issue shares under the regular purchase mechanism, restricting its ability to raise capital through this facility.
• Termination Fee: The Company faces a $250,000 termination fee if it cancels the agreement prematurely without raising a minimum amount, adding financial risk.
• Operational Risks: Any material adverse effect on the business, properties, assets, liabilities, operations, condition, or prospects of the Company or any Subsidiary could impact the Company's ability to utilize this financing effectively.
• Litigation Risk: Existing or threatened legal actions could impact the Company's operations or financial condition, potentially affecting its ability to meet obligations under the agreement.

Future Outlook

The Company intends to use the net proceeds from the offering for any corporate purpose at its sole discretion. The agreement provides a flexible mechanism for future capital raises over an 18-month period, subject to market conditions and the Company's stock price, allowing for strategic funding as needed.

Management Comments

• Management of the Company believes its insurance coverage to be prudent and customary in the businesses in which the Company and its Subsidiaries are engaged.
• The Company and its Subsidiaries believe that their relations with their employees are good.
• The Company has concluded that its internal control over financial reporting is effective and is not aware of any significant deficiencies or material weaknesses, or any fraud.
• Based on discussions with its accountants, the Company has no reason to believe that it will need to restate any of its financial statements.
• All financial projections and forecasts made available to the Investor have been prepared in good faith based upon reasonable assumptions and represented the Company’s best estimate of future financial performance, with the recognition that actual results may differ from projections.

Industry Context

The filing does not provide specific industry context or trends. It focuses on the Company's financing arrangements and corporate governance, without elaborating on broader industry dynamics or competitive landscape.

Management Changes

Corporate Governance

Legal Proceedings

• No material action, suit, arbitration, proceeding, inquiry or investigation is pending or, to the Company's knowledge, threatened against or affecting the Company or any of its Subsidiaries, the common stock, or any officers or directors.
• No investigation by the SEC involving the Company, its Subsidiaries, or any current or former director or officer is pending or contemplated.
• The SEC has not issued any stop order or other order suspending the effectiveness of any registration statement filed by the Company.
• The Company is not subject to any order, writ, judgment, injunction, decree, determination, or award of any Governmental Entity.

Related Party Transactions

• Reorganization Agreement and Plan of Share Exchange, dated February 2, 2024, by and among Coldchain Technology Services, LLC, Callan JMB Inc., and shareholders of CTS.
• Employment Agreement entered into between Callan JMB Inc. and Wayne Williams, dated October 15, 2024, as amended October 24, 2024.
• Employment Agreement entered into between Callan JMB Inc. and David J. Croyle, M.D., dated October 1, 2024, as amended October 24, 2024.
• Employment Agreement entered into between Callan JMB Inc. and Eric L. Kash, dated October 1, 2024, as amended October 24, 2024.
• Exchange and Reorganization Agreement, dated November 14, 2024, among the Company, Wayne Williams and Dr. David Croyle.
• The Company represents that, except as set forth on Schedule 4(t) (not provided in this filing), none of its officers, directors, or 10% shareholders, or their affiliates, have any direct or indirect interest in, or are party to, any transaction required to be disclosed as a related party transaction pursuant to Item 404 of Regulation S-K.

Stakeholder Impact

• Shareholders: Potential for significant dilution due to the issuance of up to $25 million in common stock at a discount to market prices. However, the financing provides capital for corporate purposes, which could support growth and operations. The prohibition on variable rate transactions (with exemptions) offers some protection against certain types of future dilutive financing.
• Company Operations: Provides a flexible source of capital to fund general corporate purposes, supporting ongoing operations and strategic initiatives, which could enhance long-term viability.
• Management: Employment agreements and equity incentive plans are in place, aligning management interests with company performance. The clawback policy enhances accountability.
• Creditors: The capital raise could improve the company's financial position and liquidity, potentially reducing credit risk.
• Investor (Hexstone Capital, LLC): Gains the right to purchase shares at a discount and resell them, with specific limitations on daily sales volume, offering a potential return on investment.

Next Steps

• The Company will file a Current Report on Form 8-K relating to the transactions contemplated by the Purchase Agreement and Registration Rights Agreement.
• The Company will file one or more registration statements covering the resale of the Purchase Shares, Exemption Purchase Shares, and other related shares.
• The Company will secure and maintain the listing of all issued shares on the Principal Market (Nasdaq Capital Market) and comply with its rules.
• The Company will obtain Shareholder Consent for the issuance of the Securities in accordance with Principal Market rules.
• The Company will issue Irrevocable Transfer Agent Instructions for the issuance of DWAC Shares to the Investor.
• The Company will use the net proceeds from the offering for general corporate purposes.

Key Dates

Recommendation

The company has secured a substantial equity financing facility, which is a positive for its liquidity and ability to fund operations. However, the dilutive nature of the share issuance at a discount to VWAP, coupled with the potential for continuous selling pressure from the investor, creates uncertainty and could weigh on the stock price. While the capital infusion is beneficial, the terms suggest a cautious approach for existing investors, warranting a 'hold' until the impact of the dilution and the company's use of proceeds become clearer. The $1.00 floor price also introduces a risk if the stock price falls below that level, limiting the company's access to this capital.

Keywords

Equity Purchase Agreement, Registration Rights, S-1/A, SEC Filing, Common Stock, Dilution, Capital Raise, Hexstone Capital, Callan JMB Inc., Public Offering, Investment, Financial Reporting, Corporate Finance, Nasdaq Capital Market, VWAP, Equity Line